Z-2044-2023Class II
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief
Appliedvr / initiated 2023-02-27 / Completed / root cause: software
Appliedvr began a recall of RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief on . FDA classified it as Class II and gives the reason as "There is the potential for the program software to malfunction which will not allow it to move forward to the next session". As of , the recall status on record is Completed, and MDM tags the root cause as software.
Recall record
- Recall number
- Z-2044-2023
- Classification
- Class II
- Status
- Completed
- Initiated
- Posted
- Recalling firm
- Appliedvr
- Product
- RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.
- Product code
- QRA Virtual Reality Behavioral Therapy Device For Pain Relief
- Reason for recall
- There is the potential for the program software to malfunction which will not allow it to move forward to the next session.
- Root cause tag
- software
- FDA root cause
- Software Manufacturing/Software Deployment
- Action
- On May, 2, 2023, AppliedVR provided customers with a Medical Device Recall notification in person. The recall notification informed the customer that the device was being recalled. For questions contact AppliedVR or your Health Care Provider.
- Quantity in commerce
- 1 unit
- Distribution
- US: NY OUS: None
- Product codes and lots
- Serial Number: PA7940RGG5130514B; UDI: 0100850038247027211001077
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2044-2023 | Class II | Completed | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
